Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › IL › HILLSIDE › MEDSTAR LABORATORY, INC

MEDSTAR LABORATORY, INC

NPI: 1144202003 · HILLSIDE, IL 60162 · Clinical Medical Laboratory · NPI assigned 11/16/2005

$37.33M
Total Medicaid Paid
3,557,236
Total Claims
3,088,190
Beneficiaries
163
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialPATEL, RAJ (VICE PRESIDENT)
NPI Enumeration Date11/16/2005

Related Entities

Other providers sharing the same authorized official: PATEL, RAJ

ProviderCityStateTotal Paid
SEA OF SMILES YARDLEY PA $183K
PEDIATRIC DENTAL HEALTH, LLC BENSALEM PA $91K
SEA OF SMILES 3PLLC WARRINGTON PA $53K
SEA OF SMILES 4 LLC JENKINTOWN PA $23K
TRUE DERMATOLOGY, LLC ALABASTER AL $915.60

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 446,712 $3.85M
2019 513,238 $4.91M
2020 565,106 $5.03M
2021 529,685 $5.36M
2022 557,488 $7.03M
2023 504,371 $5.67M
2024 440,636 $5.47M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
84443 Thyroid stimulating hormone (TSH) 193,937 170,325 $2.72M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 69,403 59,793 $2.65M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 68,335 60,061 $2.60M
80074 60,911 52,985 $2.01M
80053 Comprehensive metabolic panel 231,682 203,132 $1.98M
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 24,037 12,752 $1.67M
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 59,108 51,504 $1.46M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 259,453 228,894 $1.29M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 29,084 24,192 $1.21M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 120,928 107,252 $1.14M
80061 Lipid panel 227,455 199,659 $1.06M
83036 Hemoglobin; glycosylated (A1C) 160,092 141,166 $882K
82607 75,126 65,476 $760K
86704 51,610 44,825 $690K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 29,463 17,510 $625K
87086 Culture, bacterial; quantitative colony count, urine 72,750 61,867 $621K
86706 52,191 45,147 $621K
84436 100,304 88,353 $581K
86703 33,665 29,133 $548K
82746 54,279 46,865 $528K
84479 94,573 83,090 $520K
86708 51,688 44,903 $442K
86677 32,905 28,482 $438K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 8,924 7,685 $431K
83735 75,016 65,566 $430K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 18,036 8,082 $410K
81001 159,543 138,525 $394K
86769 7,781 4,742 $366K
82533 30,588 26,873 $360K
81513 3,937 3,457 $349K
85651 84,696 73,940 $335K
87186 33,053 25,588 $328K
83550 43,345 38,190 $320K
82728 47,656 42,247 $310K
83540 52,931 46,724 $290K
84439 38,522 34,398 $276K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 8,771 6,361 $273K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 7,316 6,343 $267K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 6,050 5,212 $242K
84153 20,675 18,363 $230K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 4,702 3,959 $219K
87481 4,428 3,718 $186K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 1,871 683 $183K
82150 31,026 27,396 $181K
83695 23,639 21,046 $178K
86592 49,289 42,890 $176K
82570 36,086 31,556 $146K
83655 13,833 12,968 $145K
86038 10,901 9,388 $139K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 2,075 1,932 $139K
82043 36,491 31,610 $130K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 5,115 4,630 $129K
80048 Basic metabolic panel (calcium, ionized) 20,107 17,475 $125K
87563 5,446 4,507 $119K
80050 General health panel 10,490 9,684 $107K
82977 32,708 29,050 $104K
84550 32,850 29,318 $102K
83615 27,600 24,561 $99K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,876 1,653 $99K
84481 9,930 8,588 $91K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 5,803 5,527 $91K
84480 10,518 9,487 $82K
83001 5,025 4,365 $81K
84100 26,265 23,516 $77K
84703 12,186 10,743 $77K
82550 17,466 15,455 $77K
36415 Collection of venous blood by venipuncture 129,139 114,722 $71K
86140 18,478 16,355 $71K
87653 1,666 1,477 $64K
86141 4,557 3,794 $59K
84403 3,064 2,662 $55K
86480 1,186 1,146 $54K
84702 6,597 5,576 $51K
86003 1,533 1,382 $51K
84146 4,233 3,706 $51K
87634 1,038 1,000 $49K
86430 9,080 7,957 $49K
86696 2,612 2,471 $46K
83002 4,500 3,881 $38K
86762 4,782 4,174 $36K
85660 8,719 7,761 $36K
86063 5,536 4,809 $35K
84402 2,168 1,962 $35K
85027 7,942 7,017 $34K
86695 2,670 2,514 $34K
86803 2,524 2,283 $30K
82248 12,055 11,007 $29K
87650 1,174 1,085 $27K
85610 8,287 6,654 $27K
83690 4,151 3,678 $24K
83090 1,822 1,751 $22K
85730 4,496 3,896 $22K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 609 528 $19K
87077 11,784 9,267 $19K
81025 6,860 6,246 $17K
86694 1,317 1,215 $16K
87340 1,588 1,444 $14K
86901 3,475 3,030 $13K
80076 3,228 2,851 $11K
86735 964 804 $11K
83525 2,645 2,410 $11K
86900 3,465 3,021 $11K
82652 634 605 $10K
87625 391 389 $10K
82785 1,491 1,402 $9K
86765 1,160 839 $9K
86787 601 525 $8K
87075 770 644 $8K
82274 832 714 $7K
87905 574 526 $6K
82378 460 416 $5K
87081 1,016 949 $5K
87808 365 364 $5K
85018 2,450 2,276 $5K
85014 2,376 2,213 $5K
82670 412 402 $4K
87450 615 595 $4K
82465 1,940 1,700 $4K
87102 682 632 $4K
83880 326 290 $4K
87070 669 607 $3K
87338 210 208 $3K
87210 792 786 $3K
80164 409 365 $3K
83970 99 99 $3K
86301 133 116 $3K
80185 230 205 $2K
86304 110 93 $2K
84144 202 188 $2K
85045 966 853 $2K
86481 61 56 $2K
84460 1,084 1,051 $1K
86780 93 88 $1K
84450 1,054 1,008 $1K
83021 123 119 $1K
82105 78 65 $1K
99000 1,108 987 $1K
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 319 240 $790.90
84432 60 51 $788.57
86235 59 59 $660.61
84156 389 366 $641.63
82950 146 132 $632.12
83721 587 540 $626.16
87522 Neg quan hep c or qual rna 12 12 $507.63
84154 52 52 $490.81
G0103 Prostate cancer screening; prostate specific antigen test (psa) 54 52 $483.55
86593 131 125 $456.81
82565 780 754 $396.66
86800 32 27 $355.98
86376 55 53 $345.68
82947 146 124 $326.17
84075 745 723 $315.19
83020 12 12 $263.72
84520 752 728 $262.59
82677 30 28 $261.97
80177 30 26 $229.48
86336 13 12 $226.04
86200 27 24 $221.39
86705 20 19 $212.28
82040 712 696 $158.27
84132 35 26 $137.71
82679 13 12 $120.45
86709 20 19 $76.57